PHAR

PHARMING GROUP NV

PHAR·71716E105·US·ADR·Healthcare - Biotechnology-13D/G

PHAR (PHARMING GROUP NV) is held by 8 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($162,340), MORGAN STANLEY ($159,735), Integrated Wealth Concepts LLC ($5,278). Net institutional sentiment: Mixed.

8
Holders
$339,016
Total Value
63% (8)
Consensus
5 buying - 3 selling
13F: Insider & Congress: Updated regularly
PHAR

Smart Money Verdict

View all
Loading verdict
Held by 8 funds

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders none · Activists Apr 7, 2025 · Congress none

ActivistMorgan StanleyMorgan Stanley1.2%Apr 7, 2025

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
11,972(+17.5%)$162,3400.0%-27.02%
18
Increased
11,500(+0.1%)$159,7350.0%-13.91%
15
New
380$5,2780.0%-13.97%
23
Decreased
300(-25.0%)$4,1670.0%-27.49%
0
New
305$4,1360.0%-13.97%
22
Decreased
187(-91.3%)$2,5960.0%-28.81%
0
New
39$5420.0%-13.97%
17
Decreased
16(-87.5%)$2220.0%-22.40%
0
PHARPHARPHARMING GROUP NV

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used